Quantcast
ALDX

Aldeyra Therapeutics, Inc. Competitors

$5.5
*  
0.22
4.17%
Get ALDX Alerts
*Delayed - data as of Jul. 23, 2019  -  Find a broker to begin trading ALDX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    ALDX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

Aldeyra Therapeutics, Inc.

CompanyName
Symbol: Market
LastSale NetChange ▲ Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Adial Pharmaceuticals, Inc
ADILW: NASDAQ-CM
$ .31 unch n/a
n/a
$ 2.4499
$ .175
NE 465
Adamas Pharmaceuticals, Inc.
ADMS: NASDAQ-GM
$ 6 unch 159,955 $ 6.13
$ 5.94
$ 29.49
$ 4.20
NE 165,198
Affimed N.V.
AFMD: NASDAQ-GM
$ 2.94 unch 555,434 $ 3
$ 2.88
$ 7.35
$ 1.40
NE 183,544
Alterity Therapeutics Limited
ATHE: NASDAQ-CM
$ 1.11 unch 52,171 $ 1.14
$ 1.10
$ 2.72
$ 1.0854
NE 9,935
Atossa Genetics Inc.
ATOS: NASDAQ-CM
$ 2.04 unch 107,500 $ 2.05
$ 2.01
$ 7.39
$ .80
NE 18,615
Benitec Biopharma Limited
BNTCW: NASDAQ-CM
$ .0273 unch n/a
n/a
$ .70
$ .021
NE 16
Cellectar Biosciences, Inc.
CLRB: NASDAQ-CM
$ 2.13 unch 46,043 $ 2.1896
$ 2.07
$ 7.15
$ 1.22
NE 11,321
Corcept Therapeutics Incorporated
CORT: NASDAQ-CM
$ 10.98 unch 489,511 $ 11.04
$ 10.83
$ 19.48
$ 9.14
18 1,261,152
ContraVir Pharmaceuticals Inc.
CTRV: NASDAQ-CM
n/a unch n/a
n/a
n/a
n/a
NE
Citius Pharmaceuticals, Inc.
CTXRW: NASDAQ-CM
$ .13 unch n/a
n/a
$ 1.28
$ .0209
NE 2,870
Cyclacel Pharmaceuticals, Inc.
CYCCP: NASDAQ-CM
$ 5.0578 unch n/a
n/a
$ 7
$ 4.46
NE 1,694
DiaMedica Therapeutics Inc.
DMAC: NASDAQ-CM
$ 3.56 unch 17,571 $ 3.56
$ 3.35
$ 5.93
$ 2.46
NE 42,567
Endo International plc
ENDP: NASDAQ-GS
$ 3.14 unch 5,143,137 $ 3.30
$ 3.12
$ 18.50
$ 3.01
NE 710,211
Evofem Biosciences, Inc.
EVFM: NASDAQ-CM
$ 5 unch 18,876 $ 5.01
$ 4.9422
$ 7.24
$ 1.7918
NE 232,395
Eyegate Pharmaceuticals, Inc.
EYEGW: NASDAQ-CM
$ .0129 unch n/a
n/a
$ .1727
$ .0116
NE 17
Galectin Therapeutics Inc.
GALT: NASDAQ-CM
$ 3.95 unch 215,766 $ 4
$ 3.91
$ 6.98
$ 3.17
NE 180,096
Geron Corporation
GERN: NASDAQ-GS
$ 1.16 unch 1,428,187 $ 1.20
$ 1.15
$ 6.99
$ .9547
NE 216,359
Horizon Therapeutics Public Limited Company
HZNP: NASDAQ-GS
$ 23.98 unch 1,381,131 $ 24.20
$ 23.63
$ 29.44
$ 16.56
92.23 4,433,518
LEAP THERAPEUTICS, INC.
LPTX: NASDAQ-GM
$ 1.92 unch 283,448 $ 1.965
$ 1.8702
$ 8.75
$ 1.35
NE 44,062
Motif Bio plc
MTFBW: NASDAQ-CM
$ .07 unch n/a
n/a
$ 5
$ .0509
NE 84
MYOS RENS Technology Inc.
MYOS: NASDAQ-CM
$ 1.68 unch 11,765 $ 1.68
$ 1.59
$ 2.02
$ 1.04
NE 15,407
NewLink Genetics Corporation
NLNK: NASDAQ-GM
$ 1.66 unch 407,270 $ 1.68
$ 1.63
$ 4.76
$ 1.2775
NE 61,878
Onconova Therapeutics, Inc.
ONTXW: NASDAQ-CM
$ .1253 unch n/a
n/a
$ .338
$ .04
NE 400
Phio Pharmaceuticals Corp.
PHIOW: NASDAQ-CM
$ .0421 unch n/a
n/a
$ .58
$ .0082
NE 54
ProPhase Labs, Inc.
PRPH: NASDAQ-CM
$ 2.06 unch n/a
n/a
$ 4
$ 2.0129
NE 23,814